-
-
-
-
-
-
-
Cocrystal Pharma Reports First Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development Programs
-
-
-
-
-
-
-
Cocrystal Pharma Increases Previously Announced Bought Deal to $15.0 Million
-
-
-
-
-
-
-
Cocrystal Pharma, Inc. (COCP) Announces $6.8 Million Registered Direct Offering of Common Stock Priced At-the-Market
-
-
-
-
-
-
-
COCRYSTAL PHARMA, INC. ANNOUNCES CLOSING OF $2.2 MILLION REGISTERED DIRECT OFFERING
-
-
-
-
-
-
-
COCRYSTAL PHARMA, INC. PRICES $3,000,000 UNDERWRITTEN PUBLIC OFFERING
-
-
-
-
-
-
-
Form S-3 Cocrystal Pharma, Inc.
-
-
-
-
-
-
-
Form S-3 Cocrystal Pharma, Inc.
-
70,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

